Run Dong
Impact in
-
- Intensive Care Unit Cognitive Disorders
Papers in
- Epidemiology 12
- Sepsis Diagnosis and Treatment 8
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Respiratory Support and Mechanisms 3
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Huaping Dai (7 shared papers)Huijuan Xiao (5 shared papers)Dingyuan Jiang (4 shared papers)Jinmin Peng (9 shared papers)Li Weng (13 shared papers)Bin Du (11 shared papers)Chunyao Wang (4 shared papers)Xiao Hu (6 shared papers)
- Journals
- Critical Care Medicine (3 papers)Annals of Intensive Care (2 papers)Scientific Reports (1 paper)Cell Death and Disease (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- ChinaSwedenUnited Kingdom
In The Last Decade
Run Dong
21 papers receiving 260 citations
Run Dong's Hit Papers
Peers
Comparison fields: 5 of 66
- Critical Care and Intensive Care Medicine 29
- Family Practice 11
- Pulmonary and Respiratory Medicine 105
- Epidemiology 91
- Applied Microbiology and Biotechnology 3
Countries citing papers authored by Run Dong
This map shows the geographic impact of Run Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Dong more than expected).
Fields of papers citing papers by Run Dong
This network shows the impact of papers produced by Run Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Dong. The network helps show where Run Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Run Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | National incidence and mortality of hospitalized sepsis in China Hit paper breakdown → | 2023 | 81 |
| 2 | 2019 | 28 | |
| 3 | Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1. | 2020 | 27 |
| 4 | 2019 | 22 | |
| 5 | 2016 | 17 | |
| 6 | 2020 | 15 | |
| 7 | 2022 | 15 | |
| 8 | 2020 | 10 | |
| 9 | 2023 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2012 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2024 | 3 | |
| 14 | 2024 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2024 | 1 |
About Run Dong
Run Dong is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Emergency Medicine and Surgery, having authored 25 papers that have together received 262 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Cardiac Arrest and Resuscitation (4 papers), Respiratory Support and Mechanisms (3 papers), Intensive Care Unit Cognitive Disorders (3 papers), Nosocomial Infections in ICU (2 papers), Hemodynamic Monitoring and Therapy (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (29 citations), Family Practice (11 citations), Pulmonary and Respiratory Medicine (105 citations), Epidemiology (91 citations) and Applied Microbiology and Biotechnology (3 citations). Run Dong has collaborated with scholars based in China, Sweden and United Kingdom. Frequent co-authors include Huaping Dai, Huijuan Xiao, Dingyuan Jiang, Jinmin Peng, Li Weng, Bin Du, Chunyao Wang, Xiao Hu, Jing Geng and Shiyao Wang. Their work appears in journals such as Critical Care Medicine, Annals of Intensive Care, Scientific Reports, Cell Death and Disease and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.